Anti-Inflammatory Effect of Cinnamomum japonicum Siebold’s Leaf through the Inhibition of p38/JNK/AP-1 Signaling

Cinnamomum japonicum Siebold (CJ) branch bark, commonly known as Japanese cinnamon, has been used for various culinary and medicinal applications for many centuries. Although the efficacy of CJ branch bark’s anti-inflammatory and antioxidant activity for the treatment of various diseases has been confirmed, the efficacy of CJ leaves (CJLs) has not been examined. We therefore investigated whether CJL3, an ethyl acetate extract of a 70% ethanol CJL extract, exerts anti-inflammatory effects on lipopolysaccharide (LPS)-activated Kupffer cells, specialized macrophages found in the liver. Liver inflammation can activate Kupffer cells, inducing the release of pro-inflammatory molecules that contribute to tissue damage. We found that CJL3 has high 2,2-diphenyl-1-picrylhydrazyl and 2,2-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) radical-scavenging activity. Among the CJL extracts, CJL3 exhibited the greatest polyphenol content, with protocatechuic acid and 4-hydroxybenzoic acid being the most abundant. In addition, we verified that CJL3, which has strong antioxidant properties, ameliorates LPS-induced pro-inflammatory responses by inhibiting p38/JNK/AP-1 signaling. CJL3 therefore has potential for treating liver disease, including hepatitis.


Introduction
Kupffer cells, specialized macrophages found in the liver, play a crucial role in maintaining liver health and function and are involved in both protective and inflammatory responses within the liver [1].In healthy individuals, Kupffer cells help clear pathogens, toxins, and debris from the bloodstream [2] and contribute to the immune response by recognizing and engulfing foreign particles and microorganisms [3].In addition, Kupffer cells produce various cytokines, chemokines, and inflammatory mediators that regulate immune responses and coordinate liver responses to injury and infection.However, in liver diseases, such as hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, and liver fibrosis, Kupffer cells may exhibit imbalanced activity [4].Liver inflammation can activate Kupffer cells, inducing the release of pro-inflammatory molecules that contribute to tissue damage.Chronic inflammation and Kupffer cell activation therefore promote the progression of liver disease [5].Regulating Kupffer cells in liver disease may therefore facilitate the development of targeted therapies.
Cinnamomum japonicum Siebold (CJ) is an evergreen tree belonging to the Lauraceae family [6].CJ is well adapted to temperate climates and can be found growing in the wild in various countries, including Korea, China, and Japan.It has leathery, oblong, dark-green leaves and smooth, grayish-brown bark.The branch bark, commonly known as Japanese cinnamon, has an aromatic flavor and has been used for various culinary and medicinal Pharmaceuticals 2023, 16, 1402 2 of 15 applications for many centuries [7].Modern pharmacological studies have demonstrated that cinnamon exhibits beneficial properties, including antioxidant, anti-inflammatory, and antimicrobial activity, blood sugar regulation, potential cardiovascular benefits, and cognitive function and neuroprotective effects [8][9][10][11].In a previous study, we found that CJ bark exhibits greater antioxidant activity than the leaves, and CJ bark have good antiinflammatory effect [12].However, the leaves had a greater extract yield than the bark, which is a great advantage in developing natural therapeutics.We therefore investigated the potential of C. japonicum Siebold's leaves for development as drug material for liver diseases such as hepatitis.We previously obtained various solvent extracts of CJ leaves (CJLs), including hot water, 70% ethanol (EtOH), and 100% EtOH extracts, as well as extracts obtained via ultrasonication, confirmed the antioxidant activities, and determined the total polyphenol and flavonoid content [13].The 70% EtOH extract exhibited the greatest antioxidant activity, as well as the greatest total phenolic and flavonoid content.In this study, we found that among the CJL extracts, CJL3 (an ethyl acetate extract of the 70% EtOH CJL extract) had the greatest radical-scavenging activity, as well as the highest polyphenol content.Furthermore, CJL3 exerted anti-inflammatory effects on lipopolysaccharide (LPS)activated Kupffer cells by inhibiting the p38/JNK/AP-1 signaling pathway, suggesting that it may be a potential candidate for the treatment of inflammatory liver disease.
Japanese cinnamon, has an aromatic flavor and has been used for various culinary and medicinal applications for many centuries [7].Modern pharmacological studies have demonstrated that cinnamon exhibits beneficial properties, including antioxidant, antiinflammatory, and antimicrobial activity, blood sugar regulation, potential cardiovascular benefits, and cognitive function and neuroprotective effects [8][9][10][11].In a previous study, we found that CJ bark exhibits greater antioxidant activity than the leaves, and CJ bark have good anti-inflammatory effect [12].However, the leaves had a greater extract yield than the bark, which is a great advantage in developing natural therapeutics.We therefore investigated the potential of C. japonicum Siebold's leaves for development as drug material for liver diseases such as hepatitis.We previously obtained various solvent extracts of CJ leaves (CJLs), including hot water, 70% ethanol (EtOH), and 100% EtOH extracts, as well as extracts obtained via ultrasonication, confirmed the antioxidant activities, and determined the total polyphenol and flavonoid content [13].The 70% EtOH extract exhibited the greatest antioxidant activity, as well as the greatest total phenolic and flavonoid content.In this study, we found that among the CJL extracts, CJL3 (an ethyl acetate extract of the 70% EtOH CJL extract) had the greatest radical-scavenging activity, as well as the highest polyphenol content.Furthermore, CJL3 exerted anti-inflammatory effects on lipopolysaccharide (LPS)-activated Kupffer cells by inhibiting the p38/JNK/AP-1 signaling pathway, suggesting that it may be a potential candidate for the treatment of inflammatory liver disease.

Suppression of Nitric Oxide (NO) and Pro-Inflammatory Cytokine Production by CJL3
To evaluate the cytotoxicity of CJL3 in an immortalized mouse Kupffer cell line (ImKC), we assessed cell viability at various CJL3 concentrations (10, 30, and 100 µg/mL).There was Pharmaceuticals 2023, 16, 1402 6 of 15 no significant difference in cell viability between the vehicle-treated group and treatment with up to 100 µg/mL CJL3 (Figure 5A).Next, we investigated the suppression of nitric oxide (NO) production by CJL3.NO, which is produced by inducible nitric oxide synthase (iNOS), has been implicated as an inflammatory mediator.Under normal physiological conditions, NO exerts anti-inflammatory effects, whereas overproduction under abnormal conditions induces inflammation.We found that CJL3 inhibits iNOS expression (Figure 5B) and LPS-induced NO production (Figure 5C).Furthermore, we investigated whether CJL3 suppresses iNOS transcription and confirmed that CJL3 reduces LPS-induced iNOS mRNA levels in ImKCs (Figure 5D).Next, we investigated the inhibitory effect of CJL3 on proinflammatory cytokine production.Pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α and interleukin (IL)-6, play essential roles in the development of various inflammatory liver diseases that result in liver cirrhosis [16].We found that pretreatment with CJL3 significantly reduces TNF-α and IL-6 mRNA levels and that CJL3 inhibits LPSinduced cytokine (TNF-α and IL-6) release (Figure 6).These results indicate that CJL3 ameliorates LPS-induced production of NO and pro-inflammatory cytokines.

Suppression of Nitric Oxide (NO) and Pro-Inflammatory Cytokine Production by CJL3
To evaluate the cytotoxicity of CJL3 in an immortalized mouse Kupffer cell line (ImKC), we assessed cell viability at various CJL3 concentrations (10, 30, and 100 µg/mL).There was no significant difference in cell viability between the vehicle-treated group and treatment with up to 100 µg/mL CJL3 (Figure 5A).Next, we investigated the suppression of nitric oxide (NO) production by CJL3.NO, which is produced by inducible nitric oxide synthase (iNOS), has been implicated as an inflammatory mediator.Under normal physiological conditions, NO exerts anti-inflammatory effects, whereas overproduction under abnormal conditions induces inflammation.We found that CJL3 inhibits iNOS expression (Figure 5B) and LPS-induced NO production (Figure 5C).Furthermore, we investigated whether CJL3 suppresses iNOS transcription and confirmed that CJL3 reduces LPS-induced iNOS mRNA levels in ImKCs (Figure 5D).Next, we investigated the inhibitory effect of CJL3 on pro-inflammatory cytokine production.Pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α and interleukin (IL)-6, play essential roles in the development of various inflammatory liver diseases that result in liver cirrhosis [16].We found that pretreatment with CJL3 significantly reduces TNF-α and IL-6 mRNA levels and that CJL3 inhibits LPS-induced cytokine (TNF-α and IL-6) release (Figure 6).These results indicate that CJL3 ameliorates LPS-induced production of NO and pro-inflammatory cytokines.Cells were pre-treated with CJL3 (10-100 µg/mL) for 1 h and then incubated with 100 ng/mL LPS for 12 h.iNOS protein levels in the cell lysates were determined using western blot (C) NO production in LPS-activated ImKCs.Cells were treated with CJL3 (30-100 µg/mL) and/or LPS for 15 h, and NO production was measured using the Griess reagent.(D) iNOS mRNA levels were determined using real-time polymerase chain reaction (RT-PCR).Cells were pre-treated with CJL3 (30-100 µg/mL) for 1 h and then incubated with 100 ng/mL LPS for 6 h.Data are presented as the mean ± standard error of the mean of three replicates; ** p < 0.01, significant versus vehicle-treated control; ## p < 0.01, # p < 0.05, significant versus LPS alone.
determined using real-time polymerase chain reaction (RT-PCR).Cells were pre-treated with CJL3 (30-100 µg/mL) for 1 h and then incubated with 100 ng/mL LPS for 6 h.Data are presented as the mean ± standard error of the mean of three replicates; ** p < 0.01, significant versus vehicle-treated control; ## p < 0.01, # p < 0.05, significant versus LPS alone.

Inhibition of the LPS-Induced p38/Jun N-Terminal Kinase (JNK)/AP-1 Signaling Pathway by CJL3
To determine whether the p38/JNK /AP-1 signaling pathway is suppressed by CJL3, we investigated whether CJL3 blocks LPS-induced degradation of IκBα, nuclear translocation of p65, and/or phosphorylation of c-Fos/c-Jun in ImKCs.IκBα inhibits the NF-κB complex by binding to and sequestering it in the cytoplasm; p65 is the major transcriptional activation domain within the NF-κB complex; and c-Fos/c-Jun proteins are the most widely studied AP-1 components.NF-κB and AP-1 are transcription factors that play crucial roles in inflammation, immunity, cell proliferation, and apoptosis [17,18].We found that LPS increases IκBα degradation, p65 nuclear translocation, and c-Fos /c-Jun phosphorylation and that CJL3 pretreatment inhibits c-Fos/c-Jun phosphorylation (Figure 7A  and B).
We investigated whether mitogen-activated protein kinase (MAPK) phosphorylation is involved in CJL3-mediated inhibition of AP-1 signaling (c-Fos/c-Jun phosphorylation).We found significantly increased ERK1/2, p38, and c-JNK phosphorylation following LPS treatment of naïve control cells, whereas p38 and JNK phosphorylation was suppressed Cells were treated with 30 µg/mL or 100 µg/mL CJL3 for 1 h and subsequently incubated with LPS for 6 h.TNF-α and IL-6 mRNA levels were determined using real-time polymerase chain reaction (RT-PCR) assays (left) and enzyme-linked immunosorbent assays (right).Data are presented as the mean ± standard error of the mean of three replicates; ** p < 0.01, significant versus vehicle-treated control; ## p < 0.01, # p < 0.05, significant versus LPS alone.

Inhibition of the LPS-Induced p38/Jun N-Terminal Kinase (JNK)/AP-1 Signaling Pathway by CJL3
To determine whether the p38/JNK /AP-1 signaling pathway is suppressed by CJL3, we investigated whether CJL3 blocks LPS-induced degradation of IκBα, nuclear translocation of p65, and/or phosphorylation of c-Fos/c-Jun in ImKCs.IκBα inhibits the NF-κB complex by binding to and sequestering it in the cytoplasm; p65 is the major transcriptional activation domain within the NF-κB complex; and c-Fos/c-Jun proteins are the most widely studied AP-1 components.NF-κB and AP-1 are transcription factors that play crucial roles in inflammation, immunity, cell proliferation, and apoptosis [17,18].We found that LPS increases IκBα degradation, p65 nuclear translocation, and c-Fos /c-Jun phosphorylation and that CJL3 pretreatment inhibits c-Fos/c-Jun phosphorylation (Figure 7A,B).

Discussion
Inflammation is a normal response of the immune system to injury or infection and is a key component of the defense mechanism against various liver diseases.However, a prolonged or excessive inflammatory response can contribute to liver damage and disease [19].During liver injury, Kupffer cells release inflammatory substances, such as cytokines

Discussion
Inflammation is a normal response of the immune system to injury or infection and is a key component of the defense mechanism against various liver diseases.However, a prolonged or excessive inflammatory response can contribute to liver damage and disease [19].During liver injury, Kupffer cells release inflammatory substances, such as cytokines and reactive oxygen species (ROS), which can further damage liver cells and contribute to the development of liver disease [20].We previously compared C. japonicum Siebold's bark and leaves and found that the bark exhibits greater antioxidant activity than the leaves.However, the extract yield of the leaves is greater than that of the bark, which is a great advantage for developing natural therapeutics [12].We therefore investigated the potential of CJL3 as a drug for suppressing inflammation during liver damage using ImKCs.
In this study, we found that the DPPH and ABTS radical-scavenging activities of CJL3 are higher than those of the other fraction samples (CJL1-5).Previous studies have reported that the 70% ethanol extract of C. cassia Blume, which belongs to the same genus as Japanese cinnamon, has an IC 50 value of 0.89 ± 0.22 mg/mL in the DPPH assay.Considering the unit conversion of approximately 890 g/mL, this confirmed the superior antioxidant activity of C. cassia Blume branches to that of the 70% ethanol extract of C. cassia Blume branches and leaves [21].In another study, a 50% ethanol extract of C. cassia Blume exhibited an antioxidant activity of approximately 90% at 100 µg/mL in the DPPH assay [22].In this study, we found that the scavenging activity of the bark extract was approximately 82% and that of the leaf extract was approximately 35% (Figure 2).
We analyzed the polyphenols in CJL3 using HPLC for screening and LC-MS/MS for quantitative analysis and obtained contradictory results (Figure 4).This may be attributed to the HPLC analyses comparing retention time with a standard, and peaks eluting at the same time may contain multiple substances.In contrast, LC-MS/MS analysis first separates the substances using HPLC, and each component is subsequently qualitatively and quantitatively analyzed using mass spectrometry.The HPLC/MS analysis was calculated from the similarity index data between the standard and sample UV spectra.As it is not a simple separation analysis, after HPLC analysis, LC-MS/MS analysis is performed for accurate analysis.
LC-MS/MS analysis of 26 polyphenols confirmed that PCA (442.00 µg/g) and 4hydroxybenzoic acid (359.00µg/g) are the major components in CJL3.Both PCA and 4-hydroxybenzoic acid are anthocyanin metabolites.A recent study comparing the antiinflammatory efficacy of PCA and 4-hydroxybenzoic acid reported that although both 4-hydroxybenzoic acid and PCA effectively target ROS-induced toxicity, only PCA targets inflammation [23].PCA has also shown promising anti-inflammatory activity in different rat models (carrageenan-induced paw edema, cotton pellet-induced granuloma, and Freund's adjuvant arthritis) of inflammation [24].PCA is widely distributed in nature and is structurally similar to the antioxidant compounds gallic, caffeic, vanillic, and syringic acids [25].There are no previous reports of the anti-inflammatory activity of 4-hydroxybenzoic acid, a single component derived from C. japonicum Siebold's leaf; therefore, the researchers' findings are significant [7].Our results therefore suggest that the antioxidant and anti-inflammatory effects of CJL3 may be caused by various polyphenol components in CJL3, including PCA and 4-hydroxybenzoic acid.
Next, we investigated whether CJL3 inhibits the inflammatory response in ImKCs.ROS serve as signaling molecules and regulate immune cell activation, migration, and function during inflammation [26].ROS contribute to the elimination of pathogens by damaging their genetic material and cellular components [27].Although ROS play a crucial role in the immune response, excessive or dysregulated ROS production can lead to oxidative stress, and prolonged or excessive oxidative stress can cause cellular lipid peroxidation, protein oxidation, and DNA damage [26], which contribute to inflammation and are associated with various inflammatory diseases.Moreover, ROS can activate redox-sensitive signaling pathways, such as MAPKs, NF-κB, and AP-1, leading to the production of proinflammatory cytokines, chemokines, and other inflammatory mediators [28].NF-κB is one of the most important transcription factors that activates the inflammatory response.In the inactive state, NF-κB is sequestered in the cytoplasm by IκBs.It is activated in response to inflammation or infection and controls the migration of inflammatory cells and the production of inflammatory molecules and increases blood vessel permeability [17,29].AP-1 is a transcription factor involved in cell proliferation and differentiation.It is activated by inflammation or infection and enhances the development and proliferation of inflammatory cells.The c-Jun/c-Fos proteins form an AP-1 complex [30], are activated by inflammation or infection, and promote the growth and proliferation of inflammatory cells.MAPKs, which include extracellular signal-regulated kinases (ERKs), p38, and c-Jun N-terminal kinase [31], are cell signaling pathways that play an important role in cell growth, death, and division [32].Numerous studies have shown that extracts exert anti-inflammatory activity by inhibiting NF-κB/AP-1/MAPK signals [33,34].Our results indicated that CJL3 specifically blocks LPS-induced AP-1/p38/JNK signaling.

Chemical Extracts of Cinnamomum japonicum Sieb. Leaf
In April 2021, Cinnamomum japonicum Sieb.leaves were collected from Wando Arboretum (Wando, Korea) in Jeollanam-do, washed, dried with hot air (40 • C), stored, and then pulverized for use.C. japonicum Sieb.leaves were collected from the arboretum located in Wando of Jeollanam-do Forest Resources Research institute (126 • 9885.42E longitude and 34 • 3154.30N latitude) according to the Wild Plant Protection Act of Korea.The morphological identification of the specimen was performed at National Institute of Biological Resources Information System (Specimen number: NIBRVP00000017321).The leaves were washed, dried with hot air (40 • C), stored, and then pulverized for use.Approximately 100 g dried C. japonicum Sieb.leaves were added to 1 L 70% ethanol and extracted at 80 • C for 6 h [35].The extract was filtered, concentrated using a reduced-pressure concentrator, and freeze-dried.The concentrated 70% ethanol extract (CJLs) was dissolved in 50% methanol and placed in a fractional funnel.Hexane was added and shaken vigorously, and the supernatant was collected after the layers separated.The supernatant was returned to the funnel, shaken with hexane, and the supernatant collected.This process was repeated 2-3 times to obtain a concentrated supernatant (CJL1).The concentrated supernatant was dissolved in distilled water and placed in a separatory funnel, and chloroform was added for further separation (CJL2).After chloroform-layer separation, ethyl acetate (EtOAc) was added to the supernatant and the layers separated (CJL3).Butanol was added to the EtOAc supernatant for further separation (CJL4 and CJL5).The separated extracts were filtered, concentrated using a reduced-pressure concentrator, and freeze-dried (Figure 1).

DPPH Radical-Scavenging Activity
DPPH radical-scavenging activity was assessed as previously described [36], with modifications.Briefly, C. japonicum Sieb.leaf extracts were prepared at concentrations of 0-2500 µg/mL, and 800 µL 0.25 mM DPPH reagent was mixed with 200 µL of each concentration of CJLs.The reaction was carried out in the dark for 30 min, and the absorbance measured at 517 nm using a Biotek Synergy HT multidetection microplate reader.Catechin was used as the positive control.

ABTS Radical-Scavenging Activity
The ABTS radical-scavenging assay was performed as previously described [37], with some modifications.Briefly, 7 mM ABTS reagent and 2.45 mM potassium persulfate were mixed in a 1:1 ratio and allowed to react in the dark for 12 h to generate ABTS radicals.Approximately 1 mL ABTS radical reagent was added to 200 µL of each concentration of C. japonicum Sieb.leaf extract.The reaction was carried out in the dark for 30 min, and the absorbance measured at 730 nm using a Biotek Synergy HT multidetection microplate reader.Catechin was used as the positive control.

TPC and TFC
TPC was determined using a modified Folin-Ciocalteu method [38].C. japonicum Sieb.leaf extract was mixed with 500 µL 0.2 M Folin-Ciocalteu phenol reagent (Sigma Aldrich, St. Louis, MO, USA) and 500 µL 2% sodium carbonate aqueous solution (w/v), allowed to react in the dark for 30 min, and the absorbance measured at 750 nm using a BioTek Synergy HT multidetection microplate reader.The final concentration of the extract was 500 µg/mL.The total phenolic content was expressed as gallic acid (GAE) mg/g equivalent and ethyl gallate (EGE) mg/g equivalent based on the black curve.
TFC was determined using the method described by Eom et al. [39].Approximately 1.5 mL methanol was added to 500 µL C. japonicum Sieb.leaf extract, followed by 100 µL 10% aluminum chloride, 100 µL 1 M potassium acetate, and 2.8 mL distilled water.The reaction was carried out at room temperature for 40 min, and absorbance measured at 415 nm using a BioTek Synergy HT multidetection microplate reader.The final concentration of the extract was 500 µg/mL.The TFC was expressed as quercetin (QUE) mg/g equivalent and rutin (RUE) mg/g equivalent based on calibration curves.

Cell Culture
ImKCs were obtained from Sigma-Aldrich (St. Louis, MO, USA) and grown in Dulbecco's modified Eagle's medium (high glucose) supplemented with 50 U/mL penicillin/streptomycin and 10% fetal bovine serum at 37 • C in a humidified 5% CO 2 atmosphere.Cells were passaged after reaching 90% confluence, detached with a cell scraper, and subcultured in a 1:5 ratio in 100 mm dishes.Cells were cultured continuously from the third to fifteenth passage.Cells were frozen every fifth passage starting from the third passage.Cells (2 × 10 5 cells/mL) were then seeded on plates and incubated for 24 h.Thereafter, it was exchanged with medium containing different concentrations of CJL3 (10, 30, and 100 µg/mL) or LPS (100 ng/mL) as a positive control.

MTT Assays
Cells were plated in 48-well plates and treated with chemicals for 24 h.Cell viability was determined by MTT staining (0.2 mg/mL, 4 h), as previously described [40].The media in the wells were removed and the produced formazan crystals were dissolved by adding 200 µL dimethyl.Absorbance was measured at 540 nm using a microplate reader (Spectramax, Molecular Devices, Sunnyvale, CA, USA).Cell viability was defined relative to the untreated control [viability (% control) = 100 × (absorbance of treated sample)/(absorbance of control]).

Analysis of Nitric Oxide Production
Cells were plated in 12-well plates and treated with CJL3 and/or LPS for 15 h.A standard curve was constructed using sodium nitrite (Sigma, St. Louis, MO, USA), and the nitrite content of the culture medium was determined by mixing the samples with Griess reagent (Sigma, St. Louis, MO, USA), as previously described [40].After incubation for 30 min, absorbance was measured at 548 nm using an ELISA microplate reader (Spectramax, Molecular Devices).

Enzyme-Linked Immunosorbent Assay (ELISA)
Cytokine (TNF-α and IL-6) levels in the culture medium were measured using ELISA kits.TNF-α and IL-6 levels were measured using an Invitrogen analyzer (Carlsbad, CA, USA).

RT-PCR Analysis
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.To obtain cDNA, total RNA (2 µg) was reversetranscribed using an oligo(dT) 16 primer.The cDNA was amplified using a high-capacity cDNA synthesis kit (Bioneer, Daejeon, Korea) and a thermal cycler (Bio-Rad, Hercules, CA, USA).Real-time PCR (RT-PCR) was performed with STEP ONE (Applied Biosystems, Foster City, CA, USA) using SYBR Green premix according to the manufacturer's instructions (Applied Biosystems).Primers were synthesized by Bioneer (Table 2).

Statistical Analysis
One-way analysis of variance was used to assess the statistical significance of differences among treatment groups.For statistically significant differences, the Newman-Keuls test was used for comparisons between multiple groups.Data were expressed as the mean ± standard error of the mean.

Conclusions
In conclusion, we found that CJL3, an ethyl acetate extract of 70% EtOH CJLs, exhibits greater antioxidant activity than the other CJL extracts.Furthermore, we identified PCA as the most abundant polyphenol in CJL3.We found that CJL3 ameliorates LPS-induced production of NO and pro-inflammatory cytokines by inhibiting p38/JNK/AP-1 signaling, thus attenuating LPS-induced pro-inflammatory responses.We therefore propose that CJL3 may be a promising candidate for treating liver disease, including hepatitis.Based on these results, future studies to investigate the effects of CJL3 in animal models of liver disease, including hepatitis, fibrosis, and cirrhosis, are warranted.

Supplementary Materials:
The following supporting information can be downloaded at: https: //www.mdpi.com/article/10.3390/ph16101402/s1,supplementary data: The compound structures confirmed by HPLC and LC-MS/MS data.

Figure 5 .
Figure 5. (A) The cytotoxicity of CJL3 in immortalized mouse Kupffer cells (ImKCs).Cells were treated with various concentrations of CJL3 (10-100 µg/mL) for 24 h, and cell viability was determined using MTT assays.(B-D) Inhibitory effect of CJL3 on LPS-induced nitric oxide (NO) production and nitric oxide synthase (iNOS) expression in ImKCs.(B) iNOS expression in LPS-activated ImKCs.Cells were pre-treated with CJL3 (10-100 µg/mL) for 1 h and then incubated with 100 ng/mL LPS for 12 h.iNOS protein levels in the cell lysates were determined using western blot (C) NO production in LPS-activated ImKCs.Cells were treated with CJL3 (30-100 µg/mL) and/or LPS for 15 h, and NO production was measured using the Griess reagent.(D) iNOS mRNA levels were

Figure 5 .
Figure 5. (A) The cytotoxicity of CJL3 in immortalized mouse Kupffer cells (ImKCs).Cells were treated with various concentrations of CJL3 (10-100 µg/mL) for 24 h, and cell viability was determined using MTT assays.(B-D) Inhibitory effect of CJL3 on LPS-induced nitric oxide (NO) production and nitric oxide synthase (iNOS) expression in ImKCs.(B) iNOS expression in LPS-activated ImKCs.Cells were pre-treated with CJL3 (10-100 µg/mL) for 1 h and then incubated with 100 ng/mL LPS for 12 h.iNOS protein levels in the cell lysates were determined using western blot (C) NO production in LPS-activated ImKCs.Cells were treated with CJL3 (30-100 µg/mL) and/or LPS for 15 h, and NO production was measured using the Griess reagent.(D) iNOS mRNA levels were determined using real-time polymerase chain reaction (RT-PCR).Cells were pre-treated with CJL3 (30-100 µg/mL) for 1 h and then incubated with 100 ng/mL LPS for 6 h.Data are presented as the mean ± standard error of the mean of three replicates; ** p < 0.01, significant versus vehicle-treated control; ## p < 0.01, # p < 0.05, significant versus LPS alone.

Figure 6 .
Figure 6.Inhibitory effect of CJL3 on LPS-induced pro-inflammatory cytokine expression in immortalized mouse Kupffer cells.(A) Tumor necrosis factor (TNF)-α and (B) interleukin (IL)-6 levels.Cells were treated with 30 µg/mL or 100 µg/mL CJL3 for 1 h and subsequently incubated with LPS for 6 h.TNF-α and IL-6 mRNA levels were determined using real-time polymerase chain reaction (RT-PCR) assays (left) and enzyme-linked immunosorbent assays (right).Data are presented as the mean ± standard error of the mean of three replicates; ** p < 0.01, significant versus vehicle-treated control; ## p < 0.01, # p < 0.05, significant versus LPS alone.

Figure 6 .
Figure 6.Inhibitory effect of CJL3 on LPS-induced pro-inflammatory cytokine expression in immortalized mouse Kupffer cells.(A) Tumor necrosis factor (TNF)-α and (B) interleukin (IL)-6 levels.Cells were treated with 30 µg/mL or 100 µg/mL CJL3 for 1 h and subsequently incubated with LPS for 6 h.TNF-α and IL-6 mRNA levels were determined using real-time polymerase chain reaction (RT-PCR) assays (left) and enzyme-linked immunosorbent assays (right).Data are presented as the mean ± standard error of the mean of three replicates; ** p < 0.01, significant versus vehicle-treated control; ## p < 0.01, # p < 0.05, significant versus LPS alone.

Table 1 .
Polyphenols identified in CJL3 and quantified using high-performance liquid chromatography.

Table 1 .
Polyphenols identified in CJL3 and quantified using high-performance liquid chromatography.

Table 2 .
Sequence for primers used in real-time quantitative PCR assays.